
Hims & Hers Health (HIMS) shares are up 20% this morning after announcing a new partnership with Novo Nordisk (NVO).
Novo Nordisk expects that teaming up with HIMS will help further expand access to its weight-loss treatment, Wegovy, which it confirmed is no longer facing supply shortages in the U.S.